Keloids: What do we know and what do we do next?

Translational Research

Volumn 159, Issue 3, 2012, Pages 173-174

  Blit, Patrick H ^a,b   Jeschke, Marc G ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN; FLUOROURACIL; VASCULOTROPIN;

DOWN REGULATION; HUMAN; KELOID; LOW LEVEL LASER THERAPY; MESENCHYMAL STEM CELL TRANSPLANTATION; NOTE; PATHOLOGY; PRIORITY JOURNAL; SKIN SURGERY; UPREGULATION;

EID: 84857287106     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.11.007     Document Type: Note

References (16)

1. J.H. Breasted The Edwin Smith surgical papyrus. Hieroglyphic translation and commentary 1930 University of Chicago Press Chicago, Ill
2. E.P. Fong, L.T. Chye, and W.T. Tan Keloids: time to dispel the myths? Plast Reconstr Surg 104 1999 1199 1202
3. A.G. Marneros, and T. Krieg Keloids - clinical diagnosis, pathogenesis, and treatment options J Dtsch Dermatol Ges 2 2004 905 913 (Pubitemid 39472352)
4. D.A. Ladin, Z. Hou, and D. Patel p53 and apoptosis alterations in keloids and keloid fibroblasts Wound Repair Regen 6 1998 28 37 (Pubitemid 128656988)
5. L. Satish, J. Lyons-Weiler, P.A. Hebda, and A. Wells Gene expression patterns in isolated keloid fibroblasts Wound Repair Regen 14 2006 463 470 (Pubitemid 44266604)
6. O. Seifert, A. Bayat, and R. Geffers Identification of unique gene expression patterns within different lesional sites of keloids Wound Repair Regen 16 2008 254 265 (Pubitemid 351342120)
7. O. Seifert, and U. Mrowietz Keloid scarring: bench and bedside Arch Dermatol Res 301 2009 259 272
8. A.G. Marneros, J.E. Norris, S. Watanabe, E. Reichenberger, and B.R. Olsen Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11 J Invest Dermatol 122 2004 1126 1132 (Pubitemid 38651086)
9. G.G. Gauglitz, H.C. Korting, T. Pavicic, T. Ruzicka, and M.G. Jeschke Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies Mol Med 17 2011 113 125
10. A. Burd, and L. Huang Hypertrophic response and keloid diathesis: two very different forms of scar Plast Reconstr Surg 116 2005 150e 157e
11. P. Durani, and A. Bayat Levels of evidence for the treatment of keloid disease J Plast Reconstr Aesthet Surg 61 2008 4 17 (Pubitemid 350199116)
12. N.S. Mogili, V.R. Krishnaswamy, M. Jayaraman, R. Rajaram, A. Venkatraman, and P.S. Korrapati Altered angiogenic balance in keloids: a key to therapeutic intervention Transl Res 159 2012 182 189
13. R.E. Fitzpatrick Treatment of inflamed hypertrophic scars using intralesional 5-FU Dermatol Surg 25 1999 224 232 (Pubitemid 29146991)
14. E. Mansilla, G.H. Marin, and F. Sturla Human mesenchymal stem cells are tolerized by mice and improve skin and spinal cord injuries Transplant Proc 37 2005 292 294 (Pubitemid 40459765)
15. M. Klinger, M. Marazzi, D. Vigo, and M. Torre Fat injection for cases of severe burn outcomes: a new perspective of scar remodeling and reduction Aesthetic Plast Surg 32 2008 465 469
16. K. Akino, S. Akita, A. Yakabe, T. Mineda, T. Hayashi, and A. Hirano Human mesenchymal stem cells may be involved in keloid pathogenesis Int J Dermatol 47 2008 1112 1117